Land: Australien
Språk: engelska
Källa: Department of Health (Therapeutic Goods Administration)
betahistine dihydrochloride, Quantity: 16 mg
Medis Pharma Pty Ltd
betahistine dihydrochloride
Tablet
Excipient Ingredients: crospovidone; lactose monohydrate; povidone; stearic acid; colloidal anhydrous silica; microcrystalline cellulose
Oral
100 tablets, 25 tablets, 10 tablets
(S4) Prescription Only Medicine
Meniere?s Syndrome as defined by the following core symptoms: ,- vertigo (with nausea/vomiting) ,- hearing loss (hardness of hearing) ,- tinnitus
Visual Identification: White to almost white, round, flat bevelled edged tablets embossed B16 on one side and scored on the other; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius
Licence status A
2015-11-10